NJ State Employees Deferred Compensation Plan’s Eledon Pharmaceuticals ELDN Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-216	Closed	-$34K	–	387
2016 Q4	$34K	Hold	216	–	–	0.01%	366
2016 Q3	$54K	Hold	216	–	–	0.01%	363
2016 Q2	$193K	Hold	216	–	–	0.04%	343
2016 Q1	$271K	Hold	216	–	–	0.06%	321
2015 Q4	$305K	Hold	216	–	–	0.06%	321
2015 Q3	$362K	Buy	+216	New	+$445K	0.08%	305

Other funds holding ELDN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's ELDN Position: Q1 2017 in Review

NJ State Employees Deferred Compensation Plan sold out of Eledon Pharmaceuticals (ELDN) in Q1 2017, closing a stake of 216 shares — an estimated $34K sold.

NJ State Employees Deferred Compensation Plan first reported a position in ELDN in Q3 2015 and held it in 6 quarters. The position peaked at $362K in Q3 2015. 34 funds tracked by Wall St. Rank hold ELDN as of Q1 2017.

NJ State Employees Deferred Compensation Plan reported no remaining Eledon Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 216 Eledon Pharmaceuticals shares in Q1 2017, an estimated $34K.
NJ State Employees Deferred Compensation Plan first reported a position in Eledon Pharmaceuticals in Q3 2015 and held it in 6 quarters.
NJ State Employees Deferred Compensation Plan's Eledon Pharmaceuticals position peaked at $362K in Q3 2015.
34 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2017.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2017, filed 27 Apr 2017.